Combating protein energy wasting in end stage kidney disease: role of exogenous proteolytic enzyme as an adjuvant to dietary protein

Authors

  • Vishal Singh Department of Medicine and Nephrology, Kanpur Cantt, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20192214

Keywords:

Chronic kidney disease, Continuous ambulatory peritoneal dialysis, Exogenous proteolytic enzyme, Protein energy wasting

Abstract

Background: Despite interventions, the prevalence of protein energy wasting in patients on dialysis continues to be unacceptably high. The objective of the study is to evaluate the efficacy of exogenous proteolytic enzyme Aminace 70000 (Hemoglobin Tyrosine Unit), as an adjuvant to dietary protein in improving the nutritional status.

Methods: This is a retrospective, real world, single centre, observational study, aimed at assessing the changes in key nutritional indices, over 6 months in patients with chronic kidney disease (CKD) initiated on continuous ambulatory peritoneal dialysis (CAPD). The intervention included addition of egg protein and use of an exogenous proteolytic enzyme. Three cohorts were identified. Cohort 1, had access to a nephrologist and CAPD counsellor; Cohort 2, in addition had access to a dietician who emphasized the need for increase in dietary protein in form of 4-6 eggs a day; and cohort 3, were in addition given an exogenous proteolytic enzyme with the major protein meal.

Results: The absolute fall in serum albumin at 6 months for the cohort 1, 2 and 3 is 0.48, 0.29 and 0.09 gm/dl respectively. Not only was the fall in serum albumin significantly less with the use of exogenous proteolytic enzyme, a higher proportion of patients were able to maintain or improve their serum albumin. The fall in midarm circumference was maximum in cohort 1 (2.08 cm) and least in cohort 3 (0.45 cm). This positive trend however, did not achieve statistical significance.

Conclusions: Use of exogenous proteolytic enzyme, when combined with egg protein, improves key nutritional indices in patients of CKD on CAPD.

References

Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950-7.

Griffiths RD. Muscle mass, survival, and the elderly ICU patient. Nutrition. 1996;12(6):456-8.

Lowrie EG, Lew NL. Death risk in hemodialysis patients: predictive value of commonly measured variables and an evaluation of death rate difference between facilities. Am J Kidney Dis. 1990;15(5):458-82.

Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391-8.

Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80(2):299-307.

Riella MC. Nutritional evaluation of patients receiving dialysis for the management of protein energy wasting: What is old and what is new?. J Ren Nutr. 2013;23(3):195-98.

Matsuzawa R, Matsunaga A, Wang G,Yamamoto S, Kutsuna, Ishii A, et al. Relationship between lower extremity muscle strength and all-cause mortality in Japanese patients undergoing dialysis. Phys Ther. 2014;94(7):947-56.

Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol. 2006;17(8):2307-14.

T. Alp Ikizler, Noel J. Cano, Harold Franch, Denis F, Jonathan H, Kamyar KZ, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: A consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096-107.

Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, et al. Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons with Hemodialysis. Am J Kidney Dis. 2011;58(3):418-28.

Fouque D, Pelletier S, Mafra D, Chauveau P. Nutrition and chronic kidney disease. Kidney Int. 2011 Aug;80(4):348-57.

Cohen SD, Kimmel PL. Nutritional status, psychological issues and survival in hemodialysis patients. Contrib Nephrol. 2007;155:1-17.

Joel D, Kopple. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis. 2001;38(4):68-73.

Kalantar-Zedeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population attributable fraction. Nephrol Dial Transplant. 2005;20(9):1880-8.

Vejakama P, Thakkinstian A, Ingsathit A, Dhanakijcharoen P, Attia J. Prognostic factors of all-cause mortalities in continuous ambulatory peritoneal dialysis: a cohort study. BMC Nephrol. 2013;14:28.

Philip Goldwasser, Joseph Feldman. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997:50(6):693-703.

Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis. 2002;40(2):307-14.

Kakiya R, Shoji T, Tsujimoto Y, Tatsumi N, Hatsuda S, Shinohara K, et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int. 2006;70(3):549-56.

Downloads

Published

2019-05-23

How to Cite

Singh, V. (2019). Combating protein energy wasting in end stage kidney disease: role of exogenous proteolytic enzyme as an adjuvant to dietary protein. International Journal of Basic & Clinical Pharmacology, 8(6), 1424–1429. https://doi.org/10.18203/2319-2003.ijbcp20192214

Issue

Section

Original Research Articles